|
Rivaroxaban with CAS 366789-02-8 is an oral anticoagulant invented and manufactured by Bayer. Rivaroxaban (CAS 366789-02-8) is an orally active direct factor Xa inhibitor. It is used to treat and prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. |
The product above are not for sales where the patents are applicable and still valid.
Rivaroxaban is a direct Factor Xa inhibitor used in anticoagulant therapy. The core synthesis involves cyclization and amide coupling. Molecular formula: C21H25ClN4O5; CAS No.: 366789-22-0.
Contraindicated in active pathological bleeding and severe hepatic impairment. Store in a dry environment below 25°C with strict moisture control to maintain chemical stability.